Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POMEROL trial: Management of moderate postoperative recurrence in Crohn's disease
2021-002369-17Phase 4Active
- Sponsor
- GETAID
- Start
- Jun 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of infliximab in Crohn's disease (2 arms), sponsored by GETAID. Started Jun 2021; status: active.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2021-002369-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002369-17.